Aemetis (AMTX) Competitors $2.62 -0.07 (-2.60%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AMTX vs. ASPI, LXFR, ARQ, SLI, SDST, ORGN, VGAS, ALTO, TLGY, and CBUSShould you be buying Aemetis stock or one of its competitors? The main competitors of Aemetis include ASP Isotopes (ASPI), Luxfer (LXFR), ARQ (ARQ), Standard Lithium (SLI), Stardust Power (SDST), Origin Materials (ORGN), Verde Clean Fuels (VGAS), Alto Ingredients (ALTO), TLGY Acquisition (TLGY), and Cibus (CBUS). These companies are all part of the "chemicals" industry. Aemetis vs. ASP Isotopes Luxfer ARQ Standard Lithium Stardust Power Origin Materials Verde Clean Fuels Alto Ingredients TLGY Acquisition Cibus ASP Isotopes (NASDAQ:ASPI) and Aemetis (NASDAQ:AMTX) are both small-cap basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, community ranking, dividends, media sentiment, institutional ownership, profitability, valuation and earnings. Do institutionals & insiders have more ownership in ASPI or AMTX? 16.8% of ASP Isotopes shares are held by institutional investors. Comparatively, 27.0% of Aemetis shares are held by institutional investors. 21.4% of ASP Isotopes shares are held by insiders. Comparatively, 15.9% of Aemetis shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more risk and volatility, ASPI or AMTX? ASP Isotopes has a beta of 3.27, indicating that its stock price is 227% more volatile than the S&P 500. Comparatively, Aemetis has a beta of 1.35, indicating that its stock price is 35% more volatile than the S&P 500. Do analysts rate ASPI or AMTX? ASP Isotopes presently has a consensus target price of $4.50, indicating a potential downside of 7.98%. Aemetis has a consensus target price of $12.95, indicating a potential upside of 394.27%. Given Aemetis' higher probable upside, analysts clearly believe Aemetis is more favorable than ASP Isotopes.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ASP Isotopes 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Aemetis 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Does the media favor ASPI or AMTX? In the previous week, ASP Isotopes had 33 more articles in the media than Aemetis. MarketBeat recorded 35 mentions for ASP Isotopes and 2 mentions for Aemetis. ASP Isotopes' average media sentiment score of 0.12 beat Aemetis' score of -0.47 indicating that ASP Isotopes is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ASP Isotopes 5 Very Positive mention(s) 4 Positive mention(s) 25 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Aemetis 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Which has better valuation & earnings, ASPI or AMTX? ASP Isotopes has higher earnings, but lower revenue than Aemetis. ASP Isotopes is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioASP Isotopes$3.38M103.18-$16.29M-$0.61-8.02Aemetis$291.40M0.45-$46.42M-$2.26-1.16 Is ASPI or AMTX more profitable? Aemetis has a net margin of -33.21% compared to ASP Isotopes' net margin of -807.39%. Aemetis' return on equity of 0.00% beat ASP Isotopes' return on equity.Company Net Margins Return on Equity Return on Assets ASP Isotopes-807.39% -123.83% -51.58% Aemetis -33.21%N/A -40.11% Does the MarketBeat Community prefer ASPI or AMTX? Aemetis received 171 more outperform votes than ASP Isotopes when rated by MarketBeat users. However, 100.00% of users gave ASP Isotopes an outperform vote while only 60.14% of users gave Aemetis an outperform vote. CompanyUnderperformOutperformASP IsotopesOutperform Votes7100.00% Underperform VotesNo VotesAemetisOutperform Votes17860.14% Underperform Votes11839.86% SummaryASP Isotopes and Aemetis tied by winning 9 of the 18 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get Aemetis News Delivered to You Automatically Sign up to receive the latest news and ratings for AMTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMTX vs. The Competition Export to ExcelMetricAemetisIndustrial organic chemicals IndustryEnergy SectorNASDAQ ExchangeMarket Cap$130.31M$2.49B$8.33B$9.07BDividend YieldN/A3.55%11.69%4.23%P/E Ratio-1.1614.3212.1517.18Price / Sales0.45993.8867.47116.95Price / CashN/A29.9110.8737.86Price / Book-0.481.533.364.78Net Income-$46.42M$8.51M$955.68M$225.60M7 Day Performance-12.96%-3.26%-3.45%-1.23%1 Month Performance-36.02%-8.77%-5.59%3.36%1 Year Performance-51.21%-24.22%1.57%16.60% Aemetis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMTXAemetis1.493 of 5 stars$2.62-2.6%$12.95+394.3%-47.9%$130.31M$291.40M-1.16160ASPIASP Isotopes0.6583 of 5 stars$5.85+17.0%$4.50-23.1%+181.0%$417.63M$3.38M-9.3176High Trading VolumeLXFRLuxfer3.4102 of 5 stars$13.81+1.3%N/A+44.8%$369.90M$384.40M41.301,400Analyst DowngradeNews CoverageARQARQ3.5382 of 5 stars$7.15+0.8%$10.00+39.9%N/A$300.53M$110.02M-709.00140Positive NewsSLIStandard Lithium1.4615 of 5 stars$1.49+0.3%$3.95+166.0%N/A$256.53MN/A2.51N/ANews CoverageSDSTStardust Power2.5706 of 5 stars$5.25-1.5%$12.50+138.1%N/A$251.66MN/A0.00N/AAnalyst ForecastNews CoverageORGNOrigin Materials3.3215 of 5 stars$1.15-0.1%$3.00+161.1%+14.1%$168.04M$35.12M-1.92160VGASVerde Clean Fuels0.1679 of 5 stars$3.64+1.4%N/A+69.8%$116.66MN/A-7.182News CoveragePositive NewsGap DownALTOAlto Ingredients3.3523 of 5 stars$1.47+0.3%$5.50+275.4%-48.1%$112.29M$1.00B-2.81420Positive NewsTLGYTLGY AcquisitionN/A$11.64flatN/A+5.1%$110.23MN/A0.003Positive NewsCBUSCibus1.6361 of 5 stars$3.96-2.9%$22.83+476.6%-82.8%$104.78M$1.82M-0.18183 Related Companies and Tools Related Companies ASPI Competitors LXFR Competitors ARQ Competitors SLI Competitors SDST Competitors ORGN Competitors VGAS Competitors ALTO Competitors TLGY Competitors CBUS Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AMTX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aemetis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aemetis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.